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Abstract.  
Purpose. We wanted to investigate the gait kinematic parameters during stairs ascent and descent after a 
fibula free flap (FFF) removal for facial reconstruction. 
Methods. Eight patients who underwent facial reconstruction with FFF ascended and descended three 
standard steps. Their movements were recorded by a motion analyzer; gait kinematic parameters were 
obtained and compared to those calculated in eight control subjects. 
Results. Stride time, percentage of swing and support phases did not differ among healthy or operated limb, 
and control subjects (Kruskal Wallis, p>0.05). No significant differences were found for hip and knee 
movements, pelvis rotation and tilt, and body center of mass displacements. During stair descent, the 
patients had a significantly larger pelvis inclination than the control subjects (p<0.05).  
Conclusion. No functional limitations during stair performance were found. The only significant difference 
could indicate a minor control of the pelvis, and should be used to define specific rehabilitative interventions. 
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Introduction 
Since its first description by Taylor et al.
1
, the fibula free flap (FFF) has been widely used to reconstruct 
segmental long bone and mandibular or maxillary defects
2-6
. The possibility to harvest the flap with only bone 
tissue or associated with muscular and skin components makes this flap indicated in the reconstruction of 
bone and soft-tissue defects of the oral cavity
7
. The FFF presents numerous advantages including: good 
bone length and quality, good length and diameter of the vascular pedicle, and ease of harvest and bone 
shaping with osteotomies
2,3
. The thickness of the fibula is adequate for positioning osteointegrated implant 
for dental prosthesis and the distance between the donor and recipient sites allows two teams to work at the 
same time
2,3,8,9
. 
Nonetheless, removal of a FFF can provoke donor site morbidity that should be attentively considered 
together with the advantages of mandibular or maxillary reconstruction. Indeed, the fibula is the origin and 
insertion of various leg and foot muscles, and the detachment and partial withdrawal of these muscles during 
fibula harvest can cause leg dysfunctions.  
Patients may not always perceive significant functional losses because of compensatory mechanisms or 
because they use the donor leg only for activities of low functional demand. It also must be noted that 
patients operated for malignancies are more tolerable of donor site morbidity considering their desire to have 
complete tumor resection and a satisfactory reconstruction.  
Over the past twenty years several studies investigated the morbidity after removal of the fibula free flap. 
These studies focused their attention on the stability of knee and ankle
10
, the differences in Range of Motion 
(RoM) of the ankle joint, the tibio-talar angle and the joint deformity
11
. Other studies evaluated the kinematic 
parameters of gait (stride length, cadence, speed, single and double support time, ankle angle) in automated 
way or under cognitive and visual engagement to identify any differences
4,10-14 
.  
No significant differences were observed about the parameters listed above considering the comparison with 
the contra-lateral side
13
, the pre-intervention X-ray images
11
, a healthy control sample
10,12
, and after 
normalization with anthropometric values
4
. Additionally, no differences regarding the strength of the medio-
lateral compartment
10
, the force of the peroneus longus and of the extensor hallucis longus
15
, the moment of 
force and power in dorsal and plantar flexion
16
, and the power output in flexion-extension of the knee and 
ankle
13
 were found. 
In particular, following the directions of the British Medical Research Council
17
, no decrease in performance 
was found by therapists in the muscles of the lower limbs
13
. Among the others, Agarwal et al.
11 
examined the 
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walking on heels and on a slope (20°), together with hopping performance, but no studies have evaluated 
the morbidity of donor site in a typical action of daily life: stairs ascent and descent. 
Moreover, in previous reports where the donor-site morbidity was considered low or absent in most patients, 
the investigators used questionnaires or clinical subjective evaluations
12,18-22
. Whenever possible, clinical 
data should be supported by quantitative instrumental evaluations allowing an objective assessment of the 
cost/ benefit ratio.   
Thus, the aim of the current preliminary study was to investigate the gait kinematic parameters and the 
displacement of the body center of mass (CoM) during the ascent and the descent performance of 3 
standard steps in a pilot group of patients who had defects of the oral cavity reconstructed by a FFF. The 
surgical group will be compared to a control group matched for age and anthropometric characteristics. 
The determination of quantitative parameters metric during the various walking phases could allow a better 
evaluation of motor performance, providing some insight into the possible adaptation or osteo-arthro-muscle 
limits of subjects submitted to FFF harvesting. In particular, evidence-based indications could be suggested 
to physicians and physiotherapists to improve the rehabilitation program. 
 
 
Materials and methods 
 
Surgical approach 
The fibula osteoseptocutaneous free flap was harvested in each patient after the execution of lower limb 
angiography and ultrasound, or angiography of the recipient vessels. In all patients the harvested FFF 
included only minimal muscle cuffs around the fibula to ensure preservation of periostal circulation. The 
motor nerve branch of the flexor hallucis longus muscle was separated from flap pedicle vessels and 
preserved.  
The fibula bone was osteotomized proximally and distally, preserving about 6 cm of bone on either 
extremities (epiphyses) to maintain knee and ankle joint stability and for the preservation of the common 
peroneal nerve.   
During the closure of surgical access, the flexor allucis longus muscle was sutured to the tibialis posterior 
muscle and to the remaining interosseous membrane with proper tension to preserve big toe flexion function. 
In patients undergoing the harvest of only bone tissue or of a little skin paddle, the skin wound was primarily 
closed. 
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A semi-rigid compressive medication was maintained for two weeks in all patients. Rehabilitation with the 
physiotherapist started 7-15 days after surgery, following a general program without specific indications for 
the fibular deficit.  
 
Patients 
Between 2005 and 2011, 22 patients underwent reconstruction of the mandibular or maxillary region with 
FFF at the Department of Maxillo Facial Surgery at the Policlinico Hospital of Milan and Galeazzi Institute of 
Milan.  
Eight of these patients (36% of the initial group) agreed to participate in this study (Table 1). At the time of 
the data collection, all the participants walked independently and without walking aids. The remaining 
patients were excluded due to refusal to participate, moving from the area, or death. All patients, after a 
detailed explanation of the protocol procedures and the risks, freely signed a consent for the evaluation and 
treatment of data that was approved by the local ethical committee. The subject under 18 years provided a 
verbal consent while a signed consent was provided by parents. All tests were not invasive, did not provoke 
pain and were not dangerous. 
The study group included four men and four women with an average age of 55 years (range 17 – 76 y) and a 
follow-up period between 6 and 60 months (Table 1).  
In five patients an osteocutaneous FFF harvest was performed, while in three patient the harvest was 
collected with only the bone component. In six patients the reconstructions with FFF were performed after 
ablation of malignant cancer, in one patient (F3) for severe osteomyelitis of the left mandibular body, and in 
one patient (M2) for pseudoarthrosis in a pathological fracture after malignant cancer ablation and 
radiotherapy. In five patients the defects involved the mandible (F2, F3, F4, M1 and M2) and in three patients 
the maxilla (F1, M3, M4).  
No patient reported pre-surgical difficulties in normal gait and in particular during stair ascent and descent. 
Before the assessment all subjects were tested following the instruction of the British Medical Research 
Council
17
, and no reductions in strength (level 5 in all muscles test) and in RoM relative to the major lower 
limb joints were found. 
A control group of similar mean age and anthropometric characteristics (standing height, body weight) was 
selected following these exclusion criteria: absence of neurological disease and any orthopedic problems, 
non-practicing sport or important physical activities but rather hobbies and free time activities similar to 
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patients (Table 2). Most of the control subjects were selected from relatives and friends of the patients. None 
had any dizziness or major visual deficits. 
All control subjects also signed the informed consent after a detailed explanation of procedures. All 
procedures were not invasive and not dangerous, and were in accordance with the Helsinki Declaration of 
1975 as revised in 1983. 
 
Procedure 
Instruments 
Data collection and analysis procedure were performed in the Laboratory for the Analysis of the Movement 
at the Department of Biomedical Sciences for Health (Università degli Studi di Milano) using a SMART 
optoelectronic computerized system (BTS, Milano). 
The system is composed of nine cameras, equipped with Charge Coupled Device technology and sensitive 
to infrared light, delimiting a working volume of 2 (width) x 3 (height) x 4 (depth) m
3
. Before each acquisition 
session, metric calibration and correction of distortions were performed using a 60-cm wand, obtaining a 
mean dynamic accuracy smaller than 0.4 mm.   
A set of 19 retroreflective markers (diameter, 1 cm) were placed on landmarks identified for their biological 
and functional value (Fig. 1). During the experiment the subjects wore a bathing suite, and the markers were 
firmly attached to the skin by means of plastic supports and double sided adhesive tape. 
 
Analysed Task 
Each subject (patients and control subjects) was asked to ascent and descend three steps. A three-step 
wood staircase with a step height of 16 cm (value similar to the stairs of the public infrastructure
23,24
 and a 
depth of 30 cm was used (Fig. 2). 
Each subject started the action 5 m before the first step
24
 to create a performance comparable to the real 
situations of daily life. All subjects performed the action at their preferred speed. Testing consisted of six 
trials: patients and control subjects started the ascent 3 times with the right limb and 3 times with the left one, 
to diversify the approach to the first step (with both the healthy and operated leg). Similarly, also the 
descending phase, after a step on the superior floor of the structure (area, 60 x 60 cm
2
; Fig. 2), was begun 
three times with the left limb and three times with the right one. 
Before data collection, all subjects became familiar with the laboratory environment and, independently, 
performed some trials up and down the stairs. Thus, they gained self-confidence and identified the starting 
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point of the march in order to climb the first step with the requested foot (right or left), without changing the 
stride and the speed gait more than 10%
24
.  
Subjects wore their habitual and comfortable footwear to recreate a real situation, and walked at their self-
chosen usual speed
24
, performing both the ascent and the descent steps without any interruption. Each 
subject performed the task without aids or assistance. 
 
Data analysis 
The 3D global reference system was defined as follows: 
- X-axis, parallel to the longitudinal direction of the symmetric stair structure, directed forward; 
- Y-axis, orthogonal to the ground, directed upward; 
- Z-axis, orthogonal to the sagittal plane (XY), directed to the right. 
All film acquisitions were separated in two distinct sequences: the ascent and the descent phases. 
Subsequently, the extremes of the gait cycle (right and left) were determined using the interval between two 
consecutive unilateral heel-strikes. Thus, the gait cycle definition allowed the normalization of the stride time 
as a percentage of the cycle. 
Then, for each gait cycle the duration of single, double support and swing phases were calculated. In 
particular, to verify different support times about operated or healthy limb, for each sequence, the percentage 
of double support was determined both for right and left steps.  
The RoM of hip flexion-extension and abduction-adduction, knee flexion-extension and pelvis rotation, 
inclination and tilt, were also calculated. All angles were computed using the landmarks placed on the skin, 
without corrections to estimate joint position
25
. The pelvis-ground relative orientations were computed using 
Euler angles (sequence: rotation around Y, flexion/extension around Z, and inclination around X) starting 
from the three landmarks positioned on the pelvis segment (sacrum, right and left anterior superior iliac 
spines). For the lower limbs, hip flexion-extension and adduction-abduction were computed as the angle 
between thigh segment and pelvis sagittal and lateral-lateral axes respectively; knee flexion–extension was 
computed as the angle between thigh and leg segments projected on the pelvis sagittal plane). 
The position of the CoM was estimated using Whittset’s model, which approximates the human body to a 
group of rigid segments
26
. In particular, we recently devised a method including 10 body segments, as 
described in detail by Mapelli et al.
27
. In brief, the 10 segments (head and neck, trunk, arms, forearms, 
thighs, and legs) are defined by a cluster of 14 markers (a subset of those recorded in the current study, Fig. 
1: right and left tragion, acromion, olecranum, radius styloid process, greater trochanter, femoral lateral 
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epicondyle, lateral malleolus). Data about the anthropometric distribution of the mass in each body segment, 
and about the location of its CoM, were taken from Zatsiorsky & Seluyanov
28
. The calculation of the total 
body CoM is obtained as a weighted-average of the CoMs of the different body segments. 
In particular, anterior-posterior (relative to the center of the pelvis) and lateral-lateral displacements of the 
CoM during the task were taken into account. 
 
Statistical analysis 
For all the analyzed variables, descriptive statistics were calculated in selected instants of the task. 
In particular, the chosen instants were the unilateral heel-strike (two consecutive, corresponding to the 0% 
and 100% instants of the gait cycle), the toe-off and the clearance of toe phase (instant during the mid 
stance in which the fingers must not touch the ground to avoid falls). 
Within subject, for each side, the mean and standard deviations of the RoM of knee (flexion-extension), hip 
(flexion-extension and abduction/ adduction), and pelvis joints (rotation, inclination and tilt) were calculated.  
Anterior-posterior and latero-lateral displacements of the CoM were also calculated. 
Patients and control subjects age and anthropometric data were compared by Mann Whitney non parametric 
test. Kinematic data were compared between patients (healthy and operated limb) and control subjects 
(average right-left data) using Kruskal Wallis non parametric test. Where necessary, post hoc tests were 
made by Mann Whitney test after correcting for the loss of degrees of freedom. For all analyses, the 
significance level was set to 5%. The effects size (ES) coefficient (d,
29
) was also calculated to determine if 
the statistically significant differences found were also clinically significant. An effect size (d) smaller than 0.3 
is considered a "small" effect (a small clinically significant difference), around 0.5 a "medium" effect, and 
larger than 0.8, a "large" effect. 
 
Results 
Age and anthropometric data of the control subjects did not differ from those of the patients (Mann Whitney 
test, all p values larger than 0.05).  
In the patient group, on average, no statistically significant differences were observed for the temporal gait 
parameters (stride time, percentage of swing and support phases) when stair performance was started with 
the healthy or the operated limb, for both ascending or descending tasks (Table 3). Additionally, no 
differences were found comparing the healthy group with the patients. In general, less time was spent during 
the descent phase than during the ascent one, with a somewhat larger swing phase.  
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Hip movements (flexion-extension and abduction-adduction) did not show significant differences between 
control and patient groups during the three phases (heel contact, toe off and clearance) and for the total 
RoM (Table 4). Within patients, actions started with healthy or pathological limb were not different.  
The flexion-extension performed by the knee during the three gait phases is shown in figure 3. No 
differences were found between control and patient group (pathological and healthy limbs) both during 
ascent and descent phase (Kruskal Wallis test, all p values > 0.05). During the ascent phase, only one 
patient reached 90 deg of flexion (clearance instant, data not shown). The mean RoM was 78 deg in the 
ascent phase while it reached 83 deg during the descent task. The flexion during foot clearance was very 
similar during the two tasks (fig. 3). 
The magnitude of pelvis movements are shown in table 5. Rotation and tilt did not show statistically 
significant differences between the actions started with the healthy or the pathological limbs, or compared to 
control subjects. In particular, during the descent phase the control group used a backward tilt (negative 
value in the table) in all three instants, while during the ascent task all subjects (in particular during heel 
contact and clearance instants) performed a counterclockwise minimal rotation. 
During the descent trials, the patients had a significantly larger RoM of pelvis inclination than the control 
subjects (Table 5). The post hoc analysis found differences between control subject movements and the 
action started by the patients with their pathological limb (p = 0.012), even if the effect size revealed a small 
clinically significant difference (d = 0.31). 
In the patients, the CoM displacements (anterior-posterior and medio-lateral directions) were in a similar 
range during actions started with the two limbs, with values very close to those observed in healthy subjects, 
and without significant differences (Fig. 4). The maximum difference was 18 mm during the descent phase 
(control group vs pathological limb). In the ascent phase, the medio-lateral CoM displacement was about 
twice than the anterior-posterior one, while similar values were estimated during the descent phase.  
 
Discussion 
Stair negotiation (ascent and descent) is an important common daily living activity. To perform the task, it is 
essential to keep a full efficiency of the limbs because larger muscular effort
24
, angular knee flexion
30
 and 
ankle RoM
31
 are needed than during level walking. 
Patients undergoing FFF harvest for reconstruction of the mandible or maxilla may present alterations in gait 
kinematics: the absence of a part of a lower limb long bone raises the question about the rehabilitation and 
the performance of a typical daily activity that could significantly affects the independence and quality of life. 
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Moreover, the fibula functions as the origin and insertion points of various leg and foot muscles, the 
detachment and injury to these muscles during fibula harvest can cause leg dysfunctions.  
Recent studies showed the absence of significant alterations in level gait performance (especially after 36 
months of follow-up)
15
, while no information is available about the gait characteristics of stair climbing. 
In the present study, patients performed the ascent and descent of three standard steps using the step-over-
step strategy that requires lower energy cost and allows higher efficiency
31
. All patients were able to perform 
the task without support (handrail) or assistance. In general, patient data were well comparable with data 
collected in a reference group of healthy subjects, and no significant differences were observed when stair 
ascent and descent were begun with the healthy or the operated lower limb.  
The stairs stride time was greater than the level walking time
32
, especially during the ascending phase (1.4 
sec). The percentage of support (on average, 65%) and swing times were very similar to those measured in 
the control group, and to literature data collected in healthy adults
23
. In comparison to level walking, the 
percentage of swing decreased because the stair height (defined according to the standard size of public 
environment
31
) was less than stride length. Also, the climbing action requires extra time to perform the major 
power output needed during the stair performance than during level walking. Indeed, in healthy subjects the 
stair ascent phase requires larger internal moments and strength in knee extension than level walking
23
. 
During the ascent and descent phases (in particular at toe off) both patients and control group showed hip 
adduction. This arrangement was used to best perform the toe off phase of gait, balancing the internal 
moment
33
. 
From our data we could define a specific motion strategy. In particular, the hip joint during the ascent task 
performed a larger RoM than during a level walking task (such as reported in literature
30
) even if the best 
contribution to bypass the step was given by the knee flexion (78° during ascent and 83° during descent). In 
the descent phase the patients used a smaller flexion-extension hip RoM
23,24
 than that reported in 
literature
30
. Our explanation, excluding strength reduction and RoM limitation that were not found, is based 
on a fear-approach to the downhill action: the patients did not use their total knee RoM. 
The rotational and tilt hip movements showed a comparable trend between healthy and pathological limb 
and similar to the reference values of the healthy group. From a clinical point of view this indicates a good 
control of the pelvis in these planes. Indeed, the value of CoM displacement in medio-lateral arrangement 
did not exceed the healthy population values
30
. The only significant difference found between the control 
group and the patients (action started with pathological side in descent phase) could indicate a minor control 
of the pelvis. 
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In conclusion, our patients submitted to a FFF for reconstruction of major defects in the oral cavity did not 
present functional limitations during stair performance. The surgical treatment reveled a general positive 
outcome: no gait impairments during stairs negotiation were found. Some differences in pelvis movement 
during the descent phase were found, and these data could be used to define specific clinical and 
rehabilitative interventions according to improve the follow-up efficacy. 
In general, we recommend: 
- increasing of motor control during load transfer especially on the pathological limb  
- increasing the strength of the gluteus to better manage the inclination of pelvis above all during descent 
phase. 
This functional analysis could define a new approach to devise specific rehabilitation protocols that are still 
absent or scantly practiced in our national health service. 
This pilot study presents some limitations: first of all the analyzed patients represent a convenience group, 
and no kind of selection was made apart from the possibility of stair climbing and descending without aids. 
Data should therefore considered with caution and require a larger group of subjects, even if previous 
investigation on this topic quantitatively assessed similar numbers of patients (from 7 to 11)
4,12,33
, and only 
Lee et al
.16
 investigated 20 patients. All previous studies concentrated on level overground gait, and in no 
occasion stair climbing was analyzed. This test allows to better investigated possible deficit in the anterior 
leg compartment (extensor hallucis longus muscle), but the current reduced number of patients prevents to 
extended our findings to all the patients submitted to the same surgical procedure.  
We analyzed only a 3-step staircase because of laboratory dimensions: during motion analysis, all the body 
landmarks must be seen by two cameras at least to ensure the 3D reconstruction of landmarks’ 
trajectories
25,27
. The system cannot be used outdoor, and higher staircases cannot be fit inside the working 
volume of the motion capture system. This experimental setting represents therefore a limitation of our study, 
but it focused on a daily activity of sufficiently but not too complex/ or difficult performance. Actually, longer 
stairs may not represent a daily trial for these patients. 
Additionally, we did not position markers on the foot because they were scarcely visible by the TV cameras 
during the task. Foot markers could improve the kinematic model allowing further analysis about ankle 
RoM
31
, the foot inclination during landing
23
, and the influence of valgus position of the foot
15
. Furthermore, 
the use of a force platform could study the dynamics of load transfer, that is the instant most frequently 
affected by falls. The promising results of this preliminary study are being used to design a multicenter study 
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focusing not only on biomechanical results but also on the various surgical approaches and rehabilitation 
procedures. 
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Table 1: Anthropometric data, follow-up time and surgical data of the analyzed patients.  
Patients 
Age 
(y) 
Weight 
(Kg) 
Height 
(cm) 
Follow-up 
(months) 
FFF type/ side Reconstructed Segment 
F1 49 52 162 60 OC right  Premaxilla 
F2 57 52 161 12 OC right Mandibular body 
F3 49 50 165 32 O left Mandibular body left 
F4 66 70 164 24 OC right Mandibular body left 
M1 17 81 190 11 O left Mandibular body left 
M2 62 75 175 6 O right  Mandibular body right 
M3 66 72 172 48 OC left Alveolar process right  
M4 76 82 174 36 OC right Maxilla 
       
mean 55 67 170 28   
SD 18 13 9 19   
OC = osteocutaneous flap,  O = bone flap. 
 
Table 2. Anthropometric data of the control group subjects.  
Subjects 
Age 
(y) 
Weight 
(Kg) 
Height 
(cm) 
F1 53 50 163 
F2 65 60 168 
M1 64 70 175 
M2 70 80 182 
M3 71 60 176 
M4 83 68 165 
M5 33 66 171 
M6 44 69 167 
    
Mean 60 65 171 
SD 16 9 6 
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Table 3. Comparison of the temporal parameters of gait during stair ascending and descending in healthy control subjects and patients. 
 
ascent  descent 
  control 
subjects 
pathological 
limb 
healthy         
limb 
control 
subjects 
pathological 
limb 
healthy         
limb   
 mean SD mean SD mean SD mean SD mean SD mean SD 
stride time (s) 1.4 0.16 1.4 0.19 1.4 0.2 1.23 0.18 1.14 0.2 1.2 0.2 
 p=0.89 p=0.64 
% support 69 2 68 2 69 1 63 2 62 4 63 2 
 p=0.21 p=0.31 
% swing 31 2 32 2 31 1 38 2 38 4 37 2 
  p=0.22 p=0.36 
 
P values: Kruskal Wallis test
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Table 4. Comparison of hip movements during stair ascending and descending in healthy control subjects and patients (unit: degrees). Negative values indicate 
adduction. 
  ascent phase descent phase 
movements phase 
control 
subjects 
pathological 
limb 
healthy         
limb 
control 
subjects 
pathological 
limb 
healthy         
limb 
  mean SD mean SD mean SD mean SD mean SD mean SD 
abd/add 
heel contact 3 4 4 5 5 7 -4 4 -4 3 -6 4 
 p=0.80 p=0.58 
toe off -4 3 -4 3 -5 5 -3 3 0 3 -3 5 
 p=0.94 p=0.21 
clearance 1 3 3 5 0 7 -3 3 -1 4 -3 5 
 p=0.74 p=0.97 
RoM 12 5 14 4 15 3 10 2 11 3 11 3 
  p=0.61 p=0.69 
              
flex/ext 
heel contact 55 5 56 6 53 6 17 5 16 7 14 6 
 p=0.71 p=0.52 
toe off 23 4 22 9 21 7 20 4 17 7 17 7 
 p=0.61 p=0.62 
clearance 49 5 47 9 46 6 29 4 27 8 27 8 
 p=0.65 p=0.50 
RoM 55 5 54 6 55 6 26 2 28 6 26 5 
  p=0.90 p=0.64 
 
P values: Kruskal Wallis test 
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Table 5. Comparison of pelvis position during stair ascending and descending in healthy control subjects and patients (unit: degrees). 
Negative values indicate inclination to the left, counterclockwise rotation and backward tilt. 
   ascent phase descent phase 
Movement phase 
control 
subjects 
pathological 
limb 
healthy  
limb 
control 
subjects 
pathological 
limb 
healthy         
limb 
  mean SD mean SD mean SD mean SD mean SD mean SD 
Inclination 
heel contact 4 2 7 4 4 4 -3 3 -3 3 -5 3 
 p=0.21 p=0.12 
toe off -2 2 -2 4 -4 4 0 2 3 3 -4 4 
 p=0.23 p=0.06 
clearance 3 2 3 4 1 5 0 2 2 4 1 5 
 p=0.5 p=0.17 
RoM 12 4 14 2 15 2 6 3 8 3 15 2 
  p=0.14 p=0.04* 
               
Rotation  
heel contact -1 4 -1 6 -5 4 2 4 4 4 0 4 
 p=09 p=0.31 
toe off 2 3 2 5 1 4 1 2 2 5 -2 4 
 p=0.58 p=0.21 
clearance -1 3 -1 6 -2 3 1 3 2 5 -2 3 
 p=0.70 p=0.20 
RoM 11 4 12 5 13 6 7 3 8 3 9 3 
  p=0.93 p=0.49 
               
Tilt 
heel contact 0 4 4 3 2 5 -2 4 0 3 -1 3 
 p=0.43 p=0.37 
toe off 6 3 8 5 9 4 -2 4 -1 3 -1 2 
 p=0.30 p=0.78 
clearance 6 3 7 4 8 4 -1 4 0 3 -1 3 
 p=0.65 p=0.71 
RoM 6 2 5 1 8 3 5 1 5 2 5 2 
    p=0.08 p=0.75 
P values: Kruskal Wallis test; * significant difference, p < 0.05; post hoc Mann Whitney test;  control subjects vs. pathological limb: p = 0.012 
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Figure legends 
 
Figure 1: Marker position: paired markers (right and left):1-3, tragi; 4-6, acromion; 7-9, olecranon; 8-10, 
styloid process of the ulna; 11-13, anterior superior iliac spine; 14-15, greater trochanter; 16-17, lateral 
epicondyle of the femur; 18-19, lateral malleolus; midline: 2, glabella, 12, spinous process of S1. 
Figure 2: Stairs structure used in the study. 
Figure 3: Knee flexion-extension during the three phases of stairs ascent and descent.  
Figure 4: Anterior-posterior and medio-lateral CoM displacement during stairs ascent and descent. 
Figure 1
Click here to download high resolution image
Figure 2
Click here to download high resolution image
Figure 3
Click here to download high resolution image
Figure 4
Click here to download high resolution image
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